Multiple roles of SOCS proteins: Differential expression of SOCS1 and SOCS3 in atherosclerosis

Liang,Xiao; He,Ming; Chen,Tao; Liu,Yan; Tian,Yu-Ling; Wu,Yu-Liang; Zhao,Yan; Shen,Yan; Yuan,Zu-Yi

doi:10.3892/ijmm.2013.1323

Multiple roles of SOCS proteins: Differential expression of SOCS1 and SOCS3 in atherosclerosis

Authors:
- Xiao Liang
- Ming He
- Tao Chen
- Yan Liu
- Yu-Ling Tian
- Yu-Liang Wu
- Yan Zhao
- Yan Shen
- Zu-Yi Yuan
View Affiliations

Affiliations: Department of Cardiovascular Medicine, The First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi’an, Shaanxi 710061, P.R. China
Published online on: March 27, 2013 https://doi.org/10.3892/ijmm.2013.1323
Pages: 1066-1074

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pro-inflammatory cytokines play a key pathogenic role in atherosclerosis, which are induced by the Janus kinase/signal transducer and activator of transduction (JAK/STAT) pathway. Furthermore, the JAK/STAT pathway is negatively regulated by the suppressor of cytokine signaling (SOCS) proteins. However, the change in SOCS expression levels and the correlation between SOCS expression and cholesterol levels in atherosclerosis is not yet well understood. To this end, a mouse model of atherosclerosis was established using apolipoprotein-deficient (ApoE-/-) mice. The mice were fed either a chow or high-fat diet. The mRNA and protein expression of SOCS1 and SOCS3 in plaque and vessels were determined at different time points. Furthermore, SOCS1 and SOCS3 mRNA expression was detected in the peripheral blood mononuclear cells (PBMCs) obtained from 18 male subjects with no coronary heart disease (non-CHD) population. The expression of SOCS1 in the ApoE-/- mice first increased and then decreased and the high-fat diet accelerated the appearance of the peak; the expression of SOCS3 increased with the increased feeding duration, and this trend was more pronounced in the mice fed the high-fat diet. SOCS1/CD68 and SOCS3/CD68 showed opposite trends in expression with the increased duration of the high-fat diet. Interleukin-6 (IL-6) expression in the main aorta of the ApoE-/- mice fed the high-fat diet also increased with the increased feeding duration. In the non-CHD population, the total serum cholesterol levels positively correlated with SOCS3 mRNA expression in the PBMCs (r=0.433, P=0.012). These results demonstrate the differential expression of SOCS1 and SOCS3 in atherosclerosis and suggest that SOCS3, together with IL-6 may promote the formation and development of atherosclerosis.

View Figures

View References

1	Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar
2	Tedgui A and Mallat Z: Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 86:515–581. 2006. View Article : Google Scholar : PubMed/NCBI
3	Ortiz-Munoz G, Martin-Ventura JL, Hernandez-Vargas P, et al: Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler Thromb Vasc Biol. 29:525–531. 2009. View Article : Google Scholar : PubMed/NCBI
4	Yan C, Cao J, Wu M, et al: Suppressor of cytokine signaling 3 inhibits LPS-induced IL-6 expression in osteoblasts by suppressing CCAAT/enhancer-binding protein {beta} activity. J Biol Chem. 285:37227–37239. 2010.PubMed/NCBI
5	Albanesi C, Fairchild HR, Madonna S, et al: IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J Immunol. 179:984–992. 2007. View Article : Google Scholar
6	Alexander WS and Hilton DJ: The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol. 22:503–529. 2004. View Article : Google Scholar : PubMed/NCBI
7	Yoshimura A, Naka T and Kubo M: SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 7:454–465. 2007. View Article : Google Scholar : PubMed/NCBI
8	Davey GM, Heath WR and Starr R: SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens. 67:1–9. 2006. View Article : Google Scholar : PubMed/NCBI
9	Egan PJ, Lawlor KE, Alexander WS and Wicks IP: Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J Clin Invest. 111:915–924. 2003. View Article : Google Scholar : PubMed/NCBI
10	Metcalf D, Di Rago L, Mifsud S, et al: The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 gene. Proc Natl Acad Sci USA. 97:9174–9179. 2000. View Article : Google Scholar : PubMed/NCBI
11	Ilangumaran S, Ramanathan S and Rottapel R: Regulation of the immune system by SOCS family adaptor proteins. Semin Immunol. 16:351–365. 2004. View Article : Google Scholar : PubMed/NCBI
12	Jo D, Liu D, Yao S, et al: Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med. 11:892–898. 2005. View Article : Google Scholar : PubMed/NCBI
13	Li Y, Chu N, Rostami A and Zhang GX: Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol. 177:1679–1688. 2006. View Article : Google Scholar : PubMed/NCBI
14	Matsumura Y, Kobayashi T, Ichiyama K, et al: Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J Immunol. 179:2170–2179. 2007. View Article : Google Scholar : PubMed/NCBI
15	Liu Y, Stewart KN, Bishop E, et al: Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo. J Immunol. 180:6270–6278. 2008. View Article : Google Scholar : PubMed/NCBI
16	O’Keefe GM, Nguyen VT, Ping Tang LL and Benveniste EN: IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein. J Immunol. 166:2260–2269. 2001.
17	Croker BA, Krebs DL, Zhang JG, et al: SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol. 4:540–545. 2003. View Article : Google Scholar : PubMed/NCBI
18	Yoshimura A, Suzuki M, Sakaguchi R, et al: SOCS, inflammation, and autoimmunity. Front Immunol. 3:202012. View Article : Google Scholar
19	Wormald S and Hilton DJ: Inhibitors of cytokine signal transduction. J Biol Chem. 279:821–824. 2004. View Article : Google Scholar : PubMed/NCBI
20	Brown MS and Goldstein JL: Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 52:223–261. 1983. View Article : Google Scholar : PubMed/NCBI
21	Gower RM, Wu H, Foster GA, et al: CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol. 31:160–166. 2011. View Article : Google Scholar
22	Gokalp D, Tuzcu A, Bahceci M, et al: Levels of proinflammatory cytokines and hs-CRP in patients with homozygous familial hypercholesterolaemia. Acta Cardiol. 64:603–609. 2009. View Article : Google Scholar : PubMed/NCBI
23	Sima AV, Stancu CS and Simionescu M: Vascular endothelium in atherosclerosis. Cell Tissue Res. 335:191–203. 2009. View Article : Google Scholar : PubMed/NCBI
24	Steinberg D: Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med. 8:1211–1217. 2002. View Article : Google Scholar : PubMed/NCBI
25	Tian Y, Yuan Z, Liu Y, et al: Pioglitazone modulates the balance of effector and regulatory T cells in apolipoprotein E deficient mice. Nutr Metab Cardiovasc Dis. 21:25–32. 2011. View Article : Google Scholar : PubMed/NCBI
26	Anderson JL, Adams CD, Antman EM, et al: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 50:e1–e157. 2007.
27	Zhao Y, Yuan Z, Liu Y, et al: Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules. J Cardiovasc Pharmacol. 55:292–298. 2010. View Article : Google Scholar : PubMed/NCBI
28	Xue JH, Yuan Z, Wu Y, et al: High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Cardiovasc Res. 86:141–150. 2010. View Article : Google Scholar
29	He L, He M, Lv X, et al: NF-kappaB binding activity and pro-inflammatory cytokines expression correlate with body mass index but not glycosylated hemoglobin in Chinese population. Diabetes Res Clin Pract. 90:73–80. 2010. View Article : Google Scholar
30	Tang J, Kozaki K, Farr AG, et al: The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE^−/− mice. Am J Pathol. 167:901–912. 2005. View Article : Google Scholar
31	Endo TA, Masuhara M, Yokouchi M, et al: A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 387:921–924. 1997. View Article : Google Scholar : PubMed/NCBI
32	Park SJ, Oh EJ, Yoo MA and Lee SH: Involvement of DNA-dependent protein kinase in regulation of stress-induced JNK activation. DNA Cell Biol. 20:637–645. 2001. View Article : Google Scholar : PubMed/NCBI
33	Kinjyo I, Hanada T, Inagaki-Ohara K, et al: SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity. 17:583–591. 2002. View Article : Google Scholar : PubMed/NCBI
34	Libby P, Ridker PM and Hansson GK: Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 54:2129–2138. 2009. View Article : Google Scholar : PubMed/NCBI
35	Li Y, Schwabe RF, DeVries-Seimon T, et al: Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. J Biol Chem. 280:21763–21772. 2005.
36	Frisdal E, Lesnik P, Olivier M, et al: Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response. J Biol Chem. 286:30926–30936. 2011. View Article : Google Scholar : PubMed/NCBI